1. Home
  2. PETS vs CLRB Comparison

PETS vs CLRB Comparison

Compare PETS & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PetMed Express Inc.

PETS

PetMed Express Inc.

HOLD

Current Price

$1.76

Market Cap

38.0M

ML Signal

HOLD

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

HOLD

Current Price

$2.52

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PETS
CLRB
Founded
1996
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.0M
12.0M
IPO Year
2003
2008

Fundamental Metrics

Financial Performance
Metric
PETS
CLRB
Price
$1.76
$2.52
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
180.0K
143.2K
Earning Date
06-09-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$273,800,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.57
$2.20
52 Week High
$4.10
$8.05

Technical Indicators

Market Signals
Indicator
PETS
CLRB
Relative Strength Index (RSI) 33.33 44.62
Support Level $1.62 N/A
Resistance Level $1.87 $3.01
Average True Range (ATR) 0.07 0.20
MACD 0.01 0.02
Stochastic Oscillator 37.75 40.68

Price Performance

Historical Comparison
PETS
CLRB

About PETS PetMed Express Inc.

PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: